1 of 1
Story summary
- UltraSight raised $24 million to expand its AI cardiac ultrasound platform in the United States.
- Financing was led by Alive HealthTech Growth Fund with Deep Insight, Star51 Capital, Connecticut Innovations and eHealth Ventures.
- A JAMA Cardiology study on Aug 28 2026 reported 93% sensitivity and 96% specificity for AI-guided aortic stenosis detection by novice operators.
- UltraSight’s Echosystem is installed in more than 10 intensive-care sites across the United States and Israel.
